ID
38538
Description
Study ID: 110948 Clinical Study ID: 110948 Study Title: Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00792636 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: sumatriptan and naproxen sodium combination tablet Trade Name: sumatriptan tablet, naproxen sodium tablet Study Indication: Migraine Disorders
Keywords
Versions (2)
- 9/22/19 9/22/19 -
- 10/24/19 10/24/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 24, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine Attacks; NCT00792636
Subject Logs
- StudyEvent: ODM
Description
Date of Visit/Assessment
Alias
- UMLS CUI-1
- C1320303
- UMLS CUI-2
- C2985720
Description
Log Status
Alias
- UMLS CUI-1
- C1708728
- UMLS CUI-2
- C0449438
Description
Serious Adverse Event
Data type
boolean
Alias
- UMLS CUI [1]
- C1519255
Description
Concomitant Agent
Data type
boolean
Alias
- UMLS CUI [1]
- C2347852
Description
Non-serious Adverse Event
Data type
boolean
Alias
- UMLS CUI [1]
- C1518404
Similar models
Subject Logs
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C2985720 (UMLS CUI-2)
C2985720 (UMLS CUI [1,2])
No comments